Connexion
E-mail
Mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

Accueil Zonebourse  >  Actions  >  Nasdaq  >  Dendreon Corporation    

DENDREON CORPORATION
Mes dernières consult.
Top consult.
  Rapport  
SynthèseActualitésAgendaSociétéFinancesFondsCommunauté 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Métier
Discovers, develops and commercializes novel products for the treatment of cancer

Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer.

The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types.

It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers.

Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA.
Dirigeants
Nom AgeDepuisTitre
Craig R. Jalbert562015President, Secretary, Treasurer & Director
William Monteith592009Executive Vice President-Technical Operations
Actions
Vote NombreFlottantAutocontrôleFlottant Total
Action A 1 158 716 893 153 327 147 96.6% 0 0.0% 96.6%
Coordonnées société
Dendreon Corp.
1208 Eastlake Avenue East
Seattle, WA 98102

Phone : +1.206.256.4545
Fax : +1.206.256.0571
Web : www.dendreon.com
Secteur Recherche biotechnologique et médicale - NCA
Var. 1janvCapitalisation (M$)
DENDREON CORPORATION0
CELLTRION, INC.--.--%33 064
IQVIA HOLDINGS INC6.98%21 789
LONZA GROUP2.35%20 356
INCYTE CORPORATION-22.94%15 565
ALNYLAM PHARMACEUTICALS, INC.-17.65%10 581
SEATTLE GENETICS, INC.22.95%10 563
NEKTAR THERAPEUTICS-2.60%9 970
EXACT SCIENCES CORPORATION31.96%8 451
QIAGEN NV6.08%8 409
ALKERMES PLC-6.16%7 963
SAGE THERAPEUTICS INC0.15%7 673
ICON PLC21.75%7 345
BIO-TECHNE CORP25.82%6 125
PRA HEALTH SCIENCES INC5.07%6 117
CHARLES RIVER LABORATORIES INTL. INC5.74%5 602
IONIS PHARMACEUTICALS INC-13.66%5 527
FIBROGEN INC34.76%5 337
UNITED THERAPEUTICS CORPORATION-20.59%5 152
GALAPAGOS7.27%5 064
FOUNDATION MEDICINE INC100.00%5 054
Connexions : Dendreon Corporation
© 2018 People , Fundamentals and Ownership